<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01024465</url>
  </required_header>
  <id_info>
    <org_study_id>2009-1</org_study_id>
    <nct_id>NCT01024465</nct_id>
  </id_info>
  <brief_title>ReShape Intragastric Balloon for the Treatment of Obesity</brief_title>
  <acronym>ITALYIII</acronym>
  <official_title>ReShape Intragastric Balloon for the Treatment of Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ReShape Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Regional Hospital. Viale Rodolfi 37. 36100 Vicenza. ITALY</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Casa di Cura Solatrix. Via Bellini 11. 38068 Rovereto. ITALY</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ReShape Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, non-randomized, open-label, multi-center study designed to implant up to
      twenty-six (26) CE-marked ReShapeâ„¢ Balloons in twenty-six (26) patients with body mass index
      (BMI) 30-40 to assess the effectiveness of the device. The RIB devices will be used within
      their labeled indications and as per their instructions for use. Enrolled patients will be
      followed for seven months. The patient will be prescribed a controlled diet, exercise and
      counseling. One group of 26 patients will receive treatment as follows: Placement, inflate to
      900 cc, remove at 180 days, follow-up 30 days post removal (endoscopic video capture of
      placement and removal required).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Weight Loss</measure>
    <time_frame>baseline to 180 days</time_frame>
    <description>Mean weight loss in kilograms compared with the baseline value through 6 months of study follow up.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>ReShape Duo Balloon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients seeking weight loss with a starting BMI in the 30-40 range, received the ReShape Duo Balloon</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReShape Duo Balloon</intervention_name>
    <description>ReShape Duo Balloon</description>
    <arm_group_label>ReShape Duo Balloon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient is male or female between the ages of 20 and 60 years of age.

          -  The patient presents with a Body Mass Index (BMI) 30-40 kg/m2.

          -  The patient is geographically stable and willing to return to the implant center for
             follow-up visits.

          -  The patient has been adequately informed of risks and requirements and consents to
             his/her participation in the post market clinical study.

        Exclusion Criteria:

          -  The patient presents with 20 years &gt; Age &gt; 60 years.

          -  The patient has a progressive disease, which in the Investigator's experience produces
             an unacceptable increased risk to the patient, or results in a life expectancy of less
             than 12 months.

          -  The patient is a pregnant or lactating female.

          -  The patient presents with a 30 kg/m2 &gt; BMI &gt; 40 kg/m2.

          -  The patient has had previous abdominal surgery.

          -  The patient has digestive tract disorders such as active peptic ulcers, bleeding
             disorders, esophageal varices, Crohn's disease.

          -  The patient presents with psychiatric disorders.

          -  The patient is participating in concomitant research studies of investigational
             products that would interfere with this study.

          -  The patient has inability to return for follow-up assessments.

          -  The patient is an alcohol or drug abuser.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary Lou Mooney</last_name>
    <role>Study Director</role>
    <affiliation>ReShape Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Casa di Cura Solatrix</name>
      <address>
        <city>Rovereto</city>
        <zip>38068</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Hospital</name>
      <address>
        <city>Vicenza</city>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 25, 2009</study_first_submitted>
  <study_first_submitted_qc>December 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2009</study_first_posted>
  <results_first_submitted>August 13, 2015</results_first_submitted>
  <results_first_submitted_qc>August 13, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 11, 2015</results_first_posted>
  <last_update_submitted>September 10, 2015</last_update_submitted>
  <last_update_submitted_qc>September 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>intragastric balloon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ReShape Duo Balloon</title>
          <description>Patients seeking weight loss with a starting BMI in the 30-40 range, received the ReShape Duo Balloon
ReShape Duo Balloon: ReShape Duo Balloon</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants were enrolled who met the study's inclusion/exclusion criteria.</population>
      <group_list>
        <group group_id="B1">
          <title>ReShape Duo Balloon</title>
          <description>Patients seeking weight loss with a starting BMI in the 30-40 range, received the ReShape Duo Balloon
ReShape Duo Balloon: ReShape Duo Balloon</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.7" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Weight Loss</title>
        <description>Mean weight loss in kilograms compared with the baseline value through 6 months of study follow up.</description>
        <time_frame>baseline to 180 days</time_frame>
        <population>Subjects with a weight recorded at 6 months</population>
        <group_list>
          <group group_id="O1">
            <title>ReShape Duo Balloon</title>
            <description>Patients seeking weight loss with a starting BMI in the 30-40 range, received the ReShape Duo Balloon
ReShape Duo Balloon: ReShape Duo Balloon</description>
          </group>
        </group_list>
        <measure>
          <title>Total Weight Loss</title>
          <description>Mean weight loss in kilograms compared with the baseline value through 6 months of study follow up.</description>
          <population>Subjects with a weight recorded at 6 months</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.4" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>180 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ReShape Duo Balloon</title>
          <description>Patients seeking weight loss with a starting BMI in the 30-40 range, received the ReShape Duo Balloon
ReShape Duo Balloon: ReShape Duo Balloon</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>verbatim</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>nausea/vomiting after discharge</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>gastric bloating</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>epigastric pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>GERD</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>ulcer at removal</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Upon study conclusion, the PI has the right to use the study data for educational purposes, scientific conferences and publications. The sponsor will have a period of 15 days (for abstracts) and 30 days (for scientific publications) to review the proposal for disclosure / publication for the sole purpose of protecting any confidential information. If such disclosure contains Confidential Information, the PI agrees to remove such Confidential Information.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No limitations nor caveats apply.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Director of Clinical Operations</name_or_title>
      <organization>ReShape Medical</organization>
      <phone>949-429-6680</phone>
      <email>lfong@reshapemedical.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

